Clinical Trial Update: A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial assessing umeclidinium for palmar hyperhidrosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis
• Palmar Hyperhidrosis

Drugs mentioned

• Umeclidinium (umeclidinium)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2018-02-09